Literature DB >> 7708976

Analysis of bronchoalveolar lavage from human lung transplant recipients by flow cytometry.

B F Whitehead1, C Stoehr, C Finkle, G Patterson, J Theodore, C Clayberger, V A Starnes.   

Abstract

Bronchoalveolar lavage (BAL) cells and peripheral blood leucocytes (PBL) from 24 lung transplant recipients were analysed for leucocyte subsets and expression of cell surface antigens. Total and differential white cell counts were performed on BAL, and lymphocyte subsets were evaluated in both BAL and peripheral blood. Measurement of immunofluorescence by flow cytometry was used to assess the percentage of: T cells (CD3+); T-helper cells (CD4+); T-cytotoxic/suppressor cells (CD8+); and activated lymphocytes (HLA-DR+). Lymphocyte subsets in BAL demonstrated marked differences to those in blood. A lower percentage of CD3+ and CD4+ lymphocytes were found in BAL, whereas CD8+ cells were more prevalent in BAL than in PBL. The mean CD4:CD8 ratio was significantly lower in BAL (1:1) than in blood (2.1:1). In the absence of pulmonary infection, there was a trend for a lower CD4:CD8 ratio in BAL associated with acute rejection (1.1:1) and obliterative bronchiolitis (1:1), when compared to the group with no evidence of rejection (1.4:1). In the absence of pulmonary rejection, pulmonary infection was associated with a marginally lower CD4:CD8 ratio in BAL (0.7:1), than when infection was absent (1.4:1). This difference was more evident in cases of cytomegalovirus (CMV) infection with a mean CD4:CD8 ratio of 0.3:1, compared to 1.5:1 in the absence of CMV disease (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7708976     DOI: 10.1016/0954-6111(95)90067-5

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection.

Authors:  Aric L Gregson; Aki Hoji; Rajan Saggar; David J Ross; Bernard M Kubak; Beth D Jamieson; S Samuel Weigt; Joseph P Lynch; Abbas Ardehali; John A Belperio; Otto O Yang
Journal:  Transplantation       Date:  2008-04-15       Impact factor: 4.939

Review 2.  Immunosuppression and allograft rejection following lung transplantation: evidence to date.

Authors:  Gregory I Snell; Glen P Westall; Miranda A Paraskeva
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 3.  Immunophenotyping of bronchoalveolar lavage lymphocytes.

Authors:  R J Harbeck
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

4.  Immunopathological changes in the airways of stable lung transplant recipients.

Authors:  G I Snell; C Ward; J W Wilson; B Orsida; T J Williams; E H Walters
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 5.  Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.

Authors:  V E Kennedy; J L Todd; S M Palmer
Journal:  Am J Transplant       Date:  2013-01-28       Impact factor: 8.086

6.  T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation.

Authors:  Sandra A Calarota; Antonella Chiesa; Annalisa De Silvestri; Monica Morosini; Tiberio Oggionni; Piero Marone; Federica Meloni; Fausto Baldanti
Journal:  J Clin Virol       Date:  2015-06-17       Impact factor: 3.168

7.  ICOS-expressing lymphocytes promote resolution of CD8-mediated lung injury in a mouse model of lung rejection.

Authors:  Qiang Wu; Gail J Gardiner; Elizabeth Berry; Sarah R Wagner; Tiffany Lu; Bryan S Clay; Tamson V Moore; Caroline M Ferreira; Jesse W Williams; Andrew D Luster; Benjamin D Medoff; Judy L Cannon; Anne I Sperling; Rebecca A Shilling
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

8.  Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation.

Authors:  F Stéphan; J F Bernaudin; D Cesari; A Fajac; D Grenet D; I Caubarrere; M Stern
Journal:  BMC Infect Dis       Date:  2001-09-17       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.